Your session is about to expire
← Back to Search
Collaborative Care for Opioid Use Disorder
Study Summary
This trial will develop and test an intervention to reduce the risk of suicide and overdose among people with opioid use disorder and PTSD/depression.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to give consent by myself.You have opioid use disorder (OUD) and also have depression and/or PTSD.I am 18 years old or older.I get my addiction and mental health medications from a doctor not in my primary care network.I am younger than 18 years old.I do not speak English or Spanish.
- Group 1: Collaborative Care Plus
- Group 2: Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor currently enrolling participants?
"According to clinicaltrials.gov, this research effort is currently recruiting volunteers; it was initially listed on August 31st 2022 and underwent its last edit on October 27th 2022."
In what number of sites is this experiment accessible?
"Patients can consider enrollment at 18 different sites, such as Clinica Sierra Vista - Kern River Health Center in Wofford Heights, Hidalgo Medical Services - Lordsburg Clinic in Lordsburg, and Providence Saint John's Health Center in Santa Monica."
What is the aggregate sum of participants in this research project?
"Indeed, the clinical trial is actively recruiting individuals. The original posting was made on August 31st 2022 and the details were recently modified on October 27th 2022. 300 participants from 18 sites are required to conclude this research project successfully."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger